冠心病合并2型糖尿病患者选择性经皮冠状动脉介入治疗特点分析Operational characteristics during selective percutaneous coronary intervention in coronary artery disease patients with type 2 diabetes mellitus
李崇剑,高润霖,杨跃进,陈纪林,徐波,乔树宾,秦学文,袁晋青,吴永健,刘海波,姚民,陈珏,戴军
摘要(Abstract)：
目的分析冠心病合并2型糖尿病患者的冠状动脉病变和经皮冠状动脉介入治疗(PCI)操作技术特点。方法对2002年1月至12月在阜外心血管病医院连续进行的1294例择期PCI并置入支架的患者进行回顾性分析,分析临床资料、介入治疗特点以及靶病变的位置、类型、长度等特征。结果糖尿病患者占20.8%,糖尿病组肥胖、女性、高血压、血脂异常、既往PCI患者的比例均较非糖尿病组高。糖尿病组右冠状动脉、双支或三支血管病变、高危险型病变显著多于非糖尿病患者。糖尿病组的平均治疗病变数及置入支架平均数均显著多于非糖尿病组患者(分别为1.63±0.82处比1.51±0.77处,1.66±0.84个比1.51±0.81个,P均<0.05)。糖尿病组术前狭窄程度、预扩张球囊平均长度、最大直径、最大充盈压力以及最长充盈时间均值都显著大于非糖尿病组[分别为91.00%±6.62%比89.81%±6.64%,17.07±6.31mm比16.07±7.28mm,2.30±1.11mm比2.12±0.94mm,996±444kPa(即9.86±4.40atm)比914±480kPa(即9.05±4.75atm),20.94±14.69s比18.26±14.65s,P均<0.05],而所置入支架平均直径则较小(3.15±0.47mm比3.23±0.43mm,P<0.05),但其他技术特征两组间差异无统计学意义(P>0.05)。糖尿病组与非糖尿病组间的PCI操作成功率、临床成功率差异无统计学意义(P>0.05)。结论冠心病合并2型糖尿病患者冠状动脉受累范围广,高危险型病变显著多于非糖尿病患者,在有选择的病例,PCI仍是治疗合并糖尿病的冠心病患者的有效手段。
关键词(KeyWords)： 冠状动脉疾病;糖尿病;血管成形术,经腔,经皮冠状动脉;预后
基金项目(Foundation):
作者(Author): 李崇剑,高润霖,杨跃进,陈纪林,徐波,乔树宾,秦学文,袁晋青,吴永健,刘海波,姚民,陈珏,戴军
参考文献(References)：
- [1]Creager MA,Luscher TH,Cosentino F,et al.Diabetes and vascular disease:pathophysiology,clinical consequences,and medical therapy.Circulation,2003,108:1527-1532.
- [2]Kornowski R,Lansky AJ.Current perspective on interventional treatment strategies in diabetic patients with coronary artery disease.Catheter Cardiovasc Interv,2000,50:245-254.
- [3]The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care,1997,20:1183-1197.
- [4]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南.中华心血管病杂志,2002,30:707-718.
- [5]Harjai KJ,Stone GW,Boura J,et al.Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction.Am J Cardiol,2003,91:1041-1045.
- [6]Laskey WK,Selzer F,Vlachos HA,et al.Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter Intervention(From the National Heart,Lung,and Blood Institute Dynamic Registry).Am J of Cardiol,2002,90:1062-1067.
- [7]Kugelmass AD,Cohen DJ,Houser F,et al.The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community:a report from the HCA database.J Invasive Cardiol,2003,15:568-574.
- [8]Mak KH,Topol EJ.Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus.J Am Coll Cardiol,2000,35:563-568.
- [9]Shindler DM,Palmeri ST,Antonelli TA,et al.Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction:a report from the SHOCK trial registry.J Am Coll Cardiol,2000,36(Suppl A):1097-1103.
- [10]Savage MP,Fischman DL,Schatz RA,et al.Coronary intervention in the diabetic patient:Improved outcomes following stent implantation compared with balloon angioplasty.Clin Cardiol,2002,25:213-217.
- [11]Lincoff AM.Important trial in cardiovascular medicine:diabetics,coronary intervention,and platelet glycoproteinⅡb/Ⅲa receptor blockade.Circulation,2003,107:1556-1559.